Vocal Biomarker Sales Surge as Investments Strengthen from Leading Manufacturers, reports Fact.MR Study
In order to dissert the market scenario
prevailing across the vocal biomarkers market sector, Fact.MR has evenly
presented a comprehensive analysis report on vocal
biomarkers market to its extensive online repository. With all vital
market facets enclosed into this single assessment, readers can learn about
different market drivers, opportunities and trends which are likely to
influence the overall market space for the vocal biomarkers market in the
coming years. In addition, factors such as market size, Y-o-Y growth and
revenue share are investigated so as to make this research highly authentic and
reliable.
Vocal patterns have been used by clinical psychologists and
psychoanalysts for analyzing personality traits of patients, and helping
creation of headway in clinical and medical investigations. Recent
breakthroughs in the healthcare sector have led to the development of a unique
diagnostic tool known as vocal biomarker, by combining the concept of
biological markers with the aforementioned methodology to analyze personality
traits. These vocal biomarkers are deemed to have immense potential in
diagnosing disease based on vocal cues. As part of ongoing breakthroughs, a
group of researchers from the New York University Langone Medical Center is
developing a machine learning-based artificial intelligence (AI) system that
would be capable of analyzing various voice characteristics that include
rhythm, tone, and pitch from patients.
Remote health monitoring potential of vocal biomarkers is also
gaining high interest among researchers worldwide, For example, Beyond Verbal
and Mayo Clinic have collaborated for discovering vocal patterns of patients
suffering from coronary artery disease. A key concept backing the development
is the impact of hardening of arteries on speech production. With advancements
in technology, vocal biomarkers will soon be able to diagnose various diseases
including certain cancers, Parkinson’s disease, and heart conditions.
Product development prevails as an imperative strategy driving
collaborating between leading companies and research institutes across various
sectors, and healthcare is no exception, Apropos of vocal biomarkers, Beyond
Verbal has developed “Beyond mHealth Research Platform”, which aims at collaborating
with universities, businesses, hospitals, and research institutes for
collectively developing unique vocal biomarkers.
Another leading player, Sonde Health Inc., has introduced
voice-based technology platform that enables diagnosing and monitoring various
conditions and diseases. The company has collaborated with Massachusetts
Institute of Technology (MIT) for licensing the technology. Such collaborations
and developments will lead to better solutions and more accurate results for
patients. It will further encourage researchers and institutions worldwide in
collecting voice data for disease diagnostics and improving outcome of
patients.
Current digital world is making rapid transformations in the way
people interact with technology and one another, with virtual private
assistants taking on a personalized experience. As virtual private assistants
such as Amazon’s Alexa become more popular & useful and smarter, developers
are focusing on providing them with additional tools that enable recognizing
emotions. A prime example of such development is the cloud-based API engine by
Beyond Verbal, which integrates with the virtual private assistants (VPAs). The
aim of Beyond Verbal’s project is to enhance the sensitivity of one’s connected
home. Focus of this cloud-based API engine is directed toward eliminating VPAs’
emotional blind spots, given that the vocal intonations in human communication
represent 35-40% of emotions conveyed. Future developments of vocal biomarkers
is likely to enable VPAs analyze voice for the specific health conditions,
providing unique insights into remote health monitoring and personalized tech.
A recently compiled report of FactMR envisages the global vocal
biomarker market to record a spectacular 23.3% CAGR between the forecast
period 2018 and 2027. Revenues from global sales of vocal biomarkers are
foreseen to surpass US$ 390 Mn by 2027-end. Beyond Verbal, Sonde Health, IBM
Corporation, and other leading participants operating in the global vocal
biomarker market have been profiled and analyzed in detail in the report.
Ask Industry
Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=719
About FactMR
FactMR is a fast-growing market research firm that offers the most
comprehensive suite of syndicated and customized market research reports. We
believe transformative intelligence can educate and inspire businesses to make
smarter decisions. We know the limitations of the one-size-fits-all approach;
that's why we publish multi-industry global, regional, and country-specific
research reports.
Comments
Post a Comment